Estrogen Shortage: What Food Can and Cannot Do

One question thread on the Swedish Medical Products Agency's forum, asking when estrogen patches will be back in pharmacies, has more than 1,500 people following it for updates. That is what the estrogen shortage looks like from the inside: not a headline, but a list of people waiting to be told something.

If you are reading this at night because you have been woken again, and the pharmacy told you today that your patch cannot be ordered, I am sorry. That is a frightening combination. The thing that was working has been taken out of your hands by a logistics problem you had no part in, and you are not being dramatic about it.

Quick answer

The estrogen shortage is not one event, and your country may be in better shape than the headline. If you cannot fill your patch, the first move is your prescriber or pharmacist, today if you can and before you run out, because there are prescription alternatives in most countries and in some places the pharmacy can substitute at the counter. Do not try to stretch what you have by cutting patches or skipping days. Food cannot replace a prescription: the honest effect size is small, around 0.79 fewer hot flashes a day for soy. What food does measurably move in menopause is cholesterol, muscle and weight, and that is worth your attention once the prescription is sorted.

I want to be careful in this article, because there is a particular kind of harm available here. A woman cannot fill her prescription, she is frightened, and the internet is ready to sell her a capsule that claims to do what the patch did. I am a nutritionist. Food is my subject, and I am going to tell you exactly where its edges are.

01

What is actually short, and where: Sweden, Finland, Norway, the US

The estrogen shortage is not one event. It is different in every country, and the difference decides what you do next.

Country Patches What the agency says
Sweden Short, all five Estradot strengths, through 31 December 2026 Tablets in good supply; gel, spray or licence prescribing listed as options
Finland Short since spring 2026 Patches and sprays worst hit, but also some gels and some oral products; end estimated around the turn of the year
Norway Access good since a second patch reached the market Estradiol Hexal dispensed instead of Estradot with no new prescription; spray still short
United States Pharmacists list an active shortage; the FDA has not declared one Ask about another patch brand, gel, spray or tablet

In Sweden, the Medical Products Agency says every strength of the Estradot patch, from 25 to 100 micrograms, is short-notified through 31 December 2026. The company expects partial deliveries during that period but says they are not expected to cover full demand.1 The agency also notes something that gets lost in the panic: estrogen tablets are in good supply.1 Whether a tablet is right for you is a different question from whether it is on the shelf, because the two routes are not interchangeable for everyone and the reasons are medical. But it means there is something concrete to ask about.

In Finland, the picture is close to Sweden's but not identical, and the difference matters. Fimea's senior inspector told Yle on 13 November 2026 that supply problems have run since the spring, that they hit skin patches and sprays hardest but also some gels and some oral products, and that based on current notifications the disruption is estimated to end around the turn of the year. She added that those dates are estimates and have already shifted several times.2 So if you are in Finland, do not assume the Swedish reassurance about tablets applies to you.

In Norway, as of September 2026 the position was better. The Norwegian Medical Products Agency reported that patch access is now good, because a second patch reached the market, and that if your pharmacy does not have Estradot you can be given Estradiol Hexal instead without a new prescription from your doctor. The estrogen spray is still tight. One detail worth knowing before you ask: swapping one patch for another needs no new prescription, but changing the form of treatment, for example from a patch to a gel, does.3

In the United States, it is stranger. Women report hunting between pharmacies for specific doses, and the American Society of Health-System Pharmacists lists estradiol transdermal systems as an active shortage. The FDA has not declared one, saying the situation does not meet its criteria and that patch supply has roughly doubled over the past year.4 Both things can be true at once: more product shipped, and still not enough of the dose you were prescribed on the shelf near you.

Before you change what you eat, check your own country's medicines agency. Your situation may be better than the headline.

02

Why this happened, which is not what most people assume

This is not a factory fire. It is demand.

In November 2025 the FDA removed the boxed warning from menopause hormone therapy, the stark black-bordered label that had sat on these products since the early 2000s and had frightened two generations of women away from them. A warning about the womb lining was kept for the combined estrogen and progestogen products, but the broad one went. Prescriptions followed. Dispensed estrogen patch prescriptions went from roughly 1.8 million in January 2025 to roughly 3.6 million by June 2026.5

Both the Norwegian and Finnish agencies describe the same thing at a wider scale: demand for menopause hormone medicines has risen significantly, suppliers cannot cover it, and several countries have supply problems. Products applied to the skin, meaning spray, patch and gel, are the hardest hit.32

I find this worth saying out loud, because the story underneath the shortage is not a bleak one. A great many women were told for twenty years that this treatment was too dangerous to consider, that advice shifted, and they went and asked for it. The supply chain simply did not expect them.

03

The first thing to do is not a grocery list

If you cannot fill your patch, the useful next step is a conversation with the person who prescribed it. Not because I am passing you along, but because the alternatives that exist are prescription alternatives, and several of them are sitting there available.

The Swedish agency's own list of options, if your patch cannot be ordered, is instructive: estrogen in tablet form, where supply is good; other products used on the skin, such as gel or spray; or licence prescribing of products approved in other countries.1 In Norway, a patch-for-patch substitution at the counter may be enough, with no new appointment at all.3 In Finland, the agency's advice is to ask the pharmacy whether another pharmacy has it, and if it cannot be substituted, to contact your doctor.2 One caution on the Swedish list: regional notices during 2026 have had patches, spray and gel short at the same time, so the better question is which of them is actually orderable where you are, this week.

None of that is a nutrition decision. Dose, route and formulation are your prescriber's territory, and whether hormone therapy suits you at all is a medical judgment that takes your own history into account. Nothing in this article is a reason to start, change, delay or stop it.

If you are close to running out, say so now rather than at the last patch. Ask your prescriber or pharmacist for an interim option while you still have a few days of supply, because that conversation is much easier before the gap than during it. And please do not try to stretch what you have by cutting patches, wearing one longer than its labelled interval, or skipping days. A transdermal patch is engineered to release a set amount over a set time. Altering it does not spread the dose thinner, it makes the dose unpredictable, and some patch designs can release their whole contents at once if they are cut. If you want to know whether anything can be done with what you have left, that is a two minute question for your pharmacist, and it is not a nutrition question.

One more thing, because the shortage has created a market. If a website offers to sell you estradiol without a prescription, or offers pellets or compounded hormones as a way around the supply problem, that is not a workaround. You cannot verify the dose, the contents or the source, and estrogen taken without the right protection for the womb lining carries real risk. Everything legitimate runs through your prescriber or your pharmacist, even in a shortage.

And if you take estrogen because of early or surgical menopause rather than natural timing, say that explicitly when you call. It changes how urgent the gap is.

For tonight, while none of the above is open yet. Nothing here treats anything, but it costs nothing: keep the room cooler than feels necessary, layer the bedding so you can throw off one layer without fully waking, keep a glass of water within reach, and leave the phone face down. Being woken is bad enough without also being woken into a bright screen at 3am.

04

What food cannot do about hot flashes, with the numbers

This is the part I would rather you heard from me than from an advert.

The best available summary of plant-based approaches to menopause symptoms is a 2016 meta-analysis in JAMA that pooled 62 randomized trials covering 6,653 women. Phytoestrogens as a group were associated with 1.31 fewer hot flashes a day, 95% confidence interval 2.02 to 0.61. Soy isoflavones specifically, whether from food or supplements, were associated with 0.79 fewer hot flashes a day. Vaginal dryness scores improved slightly. Night sweats did not improve significantly at all.6

I know that number is a disappointment. Less than one hot flash a day. If you are having ten, soy is not the answer to this problem, and I would rather hand you the real figure than a better one I do not believe. It is a genuine effect and it is a small one, and both of those things are true at the same time.

The quality underneath it is also poor. Of those 62 trials, 46, which is 74 percent, carried a high risk of bias in three or more areas of study quality.6 For red clover, the disagreement between trials was 97 percent on the standard measure of heterogeneity, which in plain terms means the studies pointed in different directions and the average between them does not describe any of them.6

One caveat that matters before the specifics: all of this applies to whole soy foods on a plate. If you have had breast cancer, or you take tamoxifen or an aromatase inhibitor, concentrated isoflavone supplements are a question for your oncology team and not a shelf decision.

So when you see the specific herbs:

Red clover. No association with the number of daily hot flashes in that pooled analysis.6

Black cohosh. In the same review it was not associated with a change in hot flashes either, 0.71 fewer per day with a confidence interval running from 2.51 fewer to 1.08 more, which crosses zero comfortably.6 It is the most heavily marketed menopause herb and it does not have the evidence its shelf position implies.

Evening primrose oil. Here the honest answer is that the trials are small and they disagree with each other. One randomized trial of 56 women found improvements in hot flash severity that beat placebo, though the differences in frequency and duration did not. Another randomized trial found no significant difference from placebo in frequency, duration or severity, while reporting fewer night sweats. A pooled analysis of four trials found no significant difference in hot flash frequency or intensity against placebo.7 That is not a basis for spending money.

You may also have seen a headline claiming a diet cut hot flashes by 78 or 84 or 88 percent. That is the WAVS trial. It randomized 38 postmenopausal women in its first report, and 84 in a later one, to a low-fat vegan diet with half a cup of cooked soybeans daily, against a control group that was asked to change nothing. It was not blinded, the design cannot separate the soy from the vegan diet, and it was funded by the organization that the lead author directs.8 I am not saying the result is false. I am saying that a 38-person unblinded trial with a do-nothing control is the thinnest possible foundation for the most dramatic number in this field, and that is why no guideline has adopted it.

There is one more piece of standard advice I have to be honest about. You have been told to avoid alcohol, caffeine and spicy food. The caffeine evidence is a single cross-sectional survey analysis where caffeine users scored 2.30 against 2.15 on a symptom bother scale, and its authors called the finding preliminary.9 The alcohol studies contradict each other. And I could not find a clinical trial that has tested whether avoiding triggers reduces hot flashes at all. If cutting your evening wine helps you sleep, that is a good enough reason to keep doing it. I only want you to know the evidence is not behind it, so that you do not blame yourself when it is not enough.

05

What food genuinely moves

None of the above means your plate is irrelevant in menopause. It means the thing it changes is not the thing you were shopping for.

Your cholesterol, and the timing is specific

The Study of Women's Health Across the Nation followed women through their final menstrual period and found that LDL cholesterol and ApoB accelerate within about one year of it, and that higher levels were associated with more coronary calcification and thicker carotid artery walls.10

This is the most actionable thing in this entire article, and almost nobody arrives worried about it. It is also the one where food has leverage rather than a rounding error. I have written the detail separately in why cholesterol rises in menopause, including what actually shifts the numbers.

Your muscle, and a result that will surprise you

Body fat tends to redistribute through the menopause transition, and muscle is one of the few parts of that you can still act on. The wellness internet has turned this into a protein arms race. The trial evidence does not support it.

A randomized trial in postmenopausal women doing resistance training compared about 1.2 g of protein per kilogram of body weight a day with the RDA of about 0.8 g, and found no difference in lean mass gain between them.11 A larger trial from the same group, 47 women, found a small additional improvement in functional capacity but not in muscle strength or lean mass quality.12

What was doing the work in both trials was the resistance training. The authors of the second one call for studies offering higher protein amounts, with longer duration and trained participants, which is a polite way of saying that the question above 1.2 g per kilogram is open rather than answered.12 So anyone quoting you a confident figure well above that is extrapolating from somewhere else. If you want the practical version of protein targets, I have gone through it in how much protein a woman should eat per day.

If you take one thing from this section. For most women, two strength sessions a week will do more for body composition in menopause than any change to the protein powder, and the trial evidence says that fairly clearly. Food supports the training. It does not substitute for it.

Your bones, where the supplement aisle oversells hardest

This section matters more than it looks, because bone loss resumes if estrogen stops, which is exactly the situation a shortage can create.

In the Women's Health Initiative trial, 36,282 postmenopausal women took either 1,000 mg of calcium with 400 IU of vitamin D or placebo, and were followed for an average of seven years. There were 175 hip fractures in the supplement group and 199 in the placebo group, which was not a statistically significant reduction. Hip bone density was 1.06 percent higher. The risk of kidney stones rose, hazard ratio 1.17, confidence interval 1.02 to 1.34.13

A 2025 meta-analysis in postmenopausal women with osteoporosis reached the same place: no significant reduction in overall fracture risk, relative risk 0.98.14 The positive findings you will see quoted come from analyses restricted to women who took 80 percent or more of their pills, which is a different question from whether being given the supplement helps.

Whether you need calcium or vitamin D depends on your diet, your blood levels and your fracture risk, and that is a conversation with your doctor, who can measure those things. What I can tell you is that the general promise on the box is not supported by the largest trial we have.

06

What to ask your prescriber during the estrogen shortage

Go in with specifics. These are the questions that, in my experience, change the outcome of the appointment.

Tonight, write these down. Tomorrow, ring the surgery and the pharmacy. Then put this article away and try to sleep.

Can I be switched to a different brand of the same patch? In Norway this is a counter-level substitution with no new prescription needed.3 Ask whether your country allows the same.

Is a tablet appropriate for me? Tablet supply is good in Sweden where patches are not,1 though in Finland some oral products have been affected too.2 Tablets and patches are not interchangeable for everyone, and the reasons are medical, so this is a question rather than a suggestion.

Would gel or spray work for me? Availability differs between these even within one country, and changing form normally needs a new prescription rather than a counter swap.13

If I cannot get estrogen at all for now, what non-hormonal options would you consider for me? There are prescription options for hot flashes that are not hormones, and there are non-drug approaches with trial evidence behind them for symptom bother and for sleep. They are not my field, which is exactly why this is a question for your prescriber rather than an answer from me. Most women do not know to ask.

Is there anything I can do with the patches I have left? Ask this instead of improvising. Whether a patch can be altered at all depends on how it is built, and that is a pharmacist's answer.

Is my vaginal estrogen a separate supply question? Local preparations are a different product from systemic patches and are often in a different supply situation, so they are worth asking about separately.

Can my dose be bridged if a delivery arrives late? The Swedish agency warns that when stock does arrive after a long shortage, demand is high and it can run out quickly, and not every pharmacy receives it.1 Knowing the plan before that happens is better than discovering it at the counter.

Should I be checking my cholesterol now? Given what the SWAN data show about the timing around the final period,10 this is a reasonable thing to raise, and it is the question that food can genuinely act on afterwards.

On the question everyone asks and nobody can answer honestly, which is how long this lasts: Sweden has notified through the end of December 2026 and Finland estimates around the turn of the year, but both are estimates and Finland's agency has said plainly that those dates have already moved more than once.12 Demand-driven shortages ease as production catches up. Nobody can tell you the week.

Want the food side of this worked out around your own situation?

A personalized plan is built around your weight, your bloods if you have recent ones, your kitchen and the time you actually have, including the cholesterol and muscle changes that are easy to miss while you are dealing with everything else.

Created by a certified nutritionist. It is nutrition, not hormone therapy, and it is designed to sit alongside whatever your doctor prescribes.

This is not the thing to sort out tonight. It will keep.

See the Personalized Meal Plan
07

What this article cannot fix

If you are having ten hot flashes a day, sleeping in four fragments and you cannot get your prescription filled, I am not going to pretend that tofu closes that gap. It does not. The gap is a supply problem and a medical one, and the people who can act on it are your prescriber and your pharmacist.

What is in your hands in the meantime is the part of menopause that moves quietly and does not announce itself: the cholesterol that starts climbing within a year of your last period, the muscle you keep or lose, the weight that redistributes. Those respond to what you eat and how you train. They will not help you sleep tonight, and I am not going to suggest otherwise. They are the part of this that is still yours while the supply problem gets sorted out, and you will be glad in five years that you did not let them drift.

If the weight side is what is bothering you most, that is a different article and I have written it properly in how to lose belly fat during menopause.

And if you came here hoping food would fill in for the patch, I would rather tell you plainly that it will not than sell you a number I do not believe. The shortage is real. So is the fact that the most useful call you make today is to your doctor.

Frequently asked questions

Is there an estrogen shortage right now?

It depends where you live. In Sweden every strength of Estradot is short-notified through 31 December 2026. In Finland the problems have run since spring 2026 and hit patches and sprays hardest, but also some gels and some oral products. In the United States pharmacists list estradiol patches as an active shortage while the FDA has not declared one. In Norway patch supply was reported as good in September 2026, with the spray still tight. Check your own country's medicines agency rather than a headline.

What should I do if I am about to run out of patches?

Contact your prescriber or pharmacist while you still have a few days left, rather than at the last patch, because an interim option is much easier to arrange before the gap than during it. Do not cut patches, wear one longer than its labelled interval, or skip days to stretch your supply: that makes the dose unpredictable rather than spreading it. If you take estrogen because of early or surgical menopause, say so when you call, because it changes how urgent the gap is.

Can diet replace estrogen therapy?

No. Nothing you eat returns estrogen to premenopausal levels. The honest effect of diet on hot flashes is small: soy isoflavones were associated with 0.79 fewer hot flashes a day across 62 randomized trials in 6,653 women. If you cannot fill your prescription, the first call is to your prescriber.

What should I eat for hot flashes during the estrogen shortage?

Nothing you eat substitutes for the prescription, so start with your prescriber. Alongside that, whole soy foods are the only dietary change with pooled randomized evidence behind them, and the effect is roughly one fewer hot flash a day. Tofu, tempeh, edamame and soy milk are reasonable to add. If you have had breast cancer or take tamoxifen or an aromatase inhibitor, concentrated isoflavone supplements are a question for your oncology team. And do not build your week around trigger avoidance: I could not find a clinical trial testing whether avoiding alcohol, caffeine or spicy food reduces hot flashes.

Do menopause supplements like black cohosh work?

The pooled evidence is weak. In the 2016 JAMA meta-analysis neither black cohosh nor red clover was associated with a change in the number of daily hot flashes, and the red clover trials disagreed with each other by 97 percent on the standard heterogeneity measure. Across all 62 trials, 46 of them carried a high risk of bias in three or more quality domains. The evening primrose trials are small and contradict each other, and a pooled analysis of four of them found no significant difference in hot flash frequency or intensity.

Will more protein protect my muscle in menopause?

Less reliably than the internet suggests. A randomized trial in postmenopausal women doing resistance training found no difference in lean mass gain between about 1.2 g of protein per kilogram a day and the RDA of about 0.8 g, and a larger trial from the same group found only a small gain in functional capacity. The training did the work. For how to set your own target, see our guide to how much protein a woman should eat per day.

Should I take calcium and vitamin D for my bones in menopause?

Ask your doctor, who can measure your levels and your fracture risk. The trial evidence is modest: in 36,282 postmenopausal women followed seven years, calcium with vitamin D did not significantly reduce hip fracture, 175 fractures against 199 on placebo, while kidney stone risk rose.

Sources

1. Läkemedelsverket (Swedish Medical Products Agency). När kommer östrogenplåster in till apoteken igen? Official forum answer, read 20 November 2026. All five Estradot strengths short-notified through 31 December 2026; partial deliveries not expected to cover demand; tablets in good supply; alternatives listed include tablets, gel, spray and licence prescribing; stock can run out quickly when deliveries arrive and not all pharmacies receive it. lakemedelsverket.se

2. Yle Uutiset. Estrogeenivalmisteista on yhä pulaa, eikä tilanteen paluuta normaaliksi voida luvata. 13 November 2026, quoting Tuija Kainulainen, senior inspector and pharmacist at Fimea, the Finnish Medicines Agency: problems since spring 2026, affecting especially skin patches and sprays but also some gels and some oral products; estimated to end around the turn of the year, with the caveat that those dates are estimates and have already changed several times; cause given as global growth in demand for hormone replacement therapy. yle.fi

3. Direktoratet for medisinske produkter (Norwegian Medical Products Agency). Forsyningssituasjonen for hormonplaster, spray og gel. Published 17 April 2024, updated 1 September 2026, read 20 November 2026. Patch access good; senior physician Ingrid Aas quoted: if the pharmacy does not have Estradot you can be given Estradiol Hexal instead and you do not need a new prescription from a doctor. Also states that changing treatment form, for example from patch to gel, does require a new prescription. Spray still short. European demand has risen significantly and suppliers cannot cover it, with skin-applied products hardest hit. dmp.no

4. NBC News. FDA claims there is no estrogen patch shortage as women struggle to get prescriptions filled. November 2026. Source for the ASHP active shortage listing and the FDA position. Reported via news coverage; we were not able to confirm the ASHP listing at ASHP's own page, which returned an error. nbcnews.com

5. Association for Accessible Medicines. Estrogen patches: how generic manufacturers have ramped up production. Analysis of IQVIA dispensing data: roughly 1.8 million dispensed estrogen patch prescriptions in January 2025 rising to roughly 3.6 million in June 2026. accessiblemeds.org

6. Franco OH, Chowdhury R, Troup J, et al. Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis. JAMA. 2016;315(23):2554-2563. doi:10.1001/jama.2016.8012. 62 randomized trials, 6,653 women. Phytoestrogens: daily hot flashes mean difference -1.31 (95% CI -2.02 to -0.61); vaginal dryness -0.31 (-0.52 to -0.10); night sweats -2.14 (-5.57 to 1.29), not significant. Soy isoflavones: -0.79 (-1.35 to -0.23). Black cohosh: -0.71 (-2.51 to 1.08), not associated. Red clover: no association, heterogeneity I² = 97%. 46 of 62 trials (74%) at high risk of bias in 3 or more domains. jamanetwork.com

7. Evening primrose oil. Farzaneh F, et al. The effect of oral evening primrose oil on menopausal hot flashes: a randomized clinical trial. Archives of Gynecology and Obstetrics, 2013. n=56, 6 weeks: severity improved more than placebo (P<0.05), frequency and duration did not. A separate single-blind randomized trial of 1,000 mg twice daily for 8 weeks found no significant difference from control in hot flash frequency, duration or severity, but fewer night sweats. A pooled analysis of four randomized trials found no significant difference in hot flash frequency or intensity versus placebo. PMID 23625331

8. Barnard and colleagues. The Women's Study for the Alleviation of Vasomotor Symptoms (WAVS), reported in Menopause, initial report 2021, n=38; and a later randomized report, A dietary intervention for vasomotor symptoms of menopause, n=84 with 71 completing, linked below. Both unblinded; the control group made no dietary change, so the design cannot separate the soy from the vegan diet; funded by the Physicians Committee for Responsible Medicine, which the lead author directs. Journal volume and page numbers not verified here. pmc.ncbi.nlm.nih.gov

9. Caffeine and menopausal symptoms: cross-sectional Mayo Clinic survey analysis published in Menopause, reported 23 July 2014, finding higher vasomotor bother scores among caffeine users (2.30 versus 2.15) and described as preliminary. Full citation and sample size not verified directly against the paper. sciencedaily.com

10. Low-density lipoprotein subclasses over the menopause transition and risk of coronary calcification and carotid atherosclerosis: the SWAN Heart and HDL ancillary studies. Significant accelerations in LDL-C and ApoB within one year of the final menstrual period; higher LDL particle number and ApoB associated with greater coronary artery calcification prevalence and greater carotid intima-media thickness. pmc.ncbi.nlm.nih.gov

11. Rossato and colleagues. Higher Protein Intake Does Not Improve Lean Mass Gain When Compared with RDA Recommendation in Postmenopausal Women Following Resistance Exercise Protocol: A Randomized Clinical Trial, 2017. n=23, 10 weeks, approximately 1.2 versus 0.8 g/kg/day. ncbi.nlm.nih.gov

12. Moderate Increase in Protein Intake Promotes a Small Additional Improvement in Functional Capacity, But Not in Muscle Strength and Lean Mass Quality, in Postmenopausal Women Following Resistance Exercise: A Randomized Clinical Trial. Same research group as reference 11. n=47, approximately 0.8 g/kg/day (n=25) versus 1.2 g/kg/day (n=22). The authors conclude that further studies with longer duration, higher protein amounts and trained individuals are needed. ncbi.nlm.nih.gov

13. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. New England Journal of Medicine. 2006;354(7):669-683. doi:10.1056/NEJMoa055218. 36,282 postmenopausal women aged 50 to 79, 1,000 mg calcium carbonate plus 400 IU vitamin D3 daily, average follow-up 7.0 years. 175 hip fractures on supplementation versus 199 on placebo; no significant reduction in hip fracture. Hip bone density 1.06% higher. Renal calculi hazard ratio 1.17 (95% CI 1.02 to 1.34). PMID 16481635

14. Systematic review and meta-analysis of randomized controlled trials on combined calcium and vitamin D supplementation in postmenopausal women with osteoporosis. BMC Musculoskeletal Disorders, 2025. Overall fracture risk not significantly reduced, RR 0.98 (95% CI 0.89 to 1.07, p = 0.68). pmc.ncbi.nlm.nih.gov


Cherry Season — Six Pairings free guide cover by Krista, Slim Fit Nutrition
Free · Summer edition

Cherry Season — Six Pairings

Six simple ways to enjoy cherries at their best. No cooking, no calorie counting — just pairings that work, written the way I write them for clients.

  • ✦Six pairings, from burrata and basil to dark chocolate and almonds
  • ✦Exact amounts per serving, in grams and ounces
  • ✦One page per recipe, made to print or keep on your phone

Free PDF, straight to your inbox. A new edition every season. Unsubscribe any time.

From
$70.00
Get my meal plan